Slovakia’s new Government plans to cut VAT on drugs to 5% from the current 19%.
Our view: This may support Zentiva’s sales in Slovakia, which have been suffering from the recently introduced healthcare reform. In the 1Q06, Slovakia’s sales declined by 5.5% y/y to CZK455m and formed 15% on Zentiva’s total pharmaceutical sales compared to 20% a year ago.